Replies to post #4042 on NDT Pharmaceuticals Inc (NDTP)

[crappyg1]

nah, seems to fall in line with my previous snippet

Robert deZanger, CEO of Natures Bioceuticals reiterates his previous statement “The implications of this natural medicine formula are mind boggling both in terms of the increased quality of life to the people who need it and the potential revenues to the company. There are over 20 different prescription drugs for this condition currently on the market and many of them have multi-billion dollar annual sales. We are anxious to have the formal closing and transfer of the rights as soon as possible so we can file a patent on the formula. We will then immediately start clinical trials to validate the veracity of the initial study. If the new expanded control group responds in a similar manner to the initial result this should be a product that will have far reaching implications and should generate acquisition interest from the major pharmaceutical and natural product companies.”

[crappyg1]

Oh and for the financials. If you were following this from the beginning then you would know that merger happened a couple months prior to what the report from april reflects. So that would be from late October to the end of last year. As far as we all know there were no sales until March. You stated that you can read, so do your analysis on any future reports (if they choose to disclose them) and come back with that again.

To say it another way. The evidence that you are trying to provide may or may not reflect the current situation. We just have to wait and see...